AUTONOMIX MEDICAL INC (AMIX)
US05330T1060 - Common Stock
Taking everything into account, AMIX scores 1 out of 10 in our fundamental rating. AMIX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of AMIX is average, but there are quite some concerns on its profitability. AMIX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
AMIX had negative earnings in the past year.
In the past year AMIX has reported a negative cash flow from operations.
1.2 Ratios
Looking at the Return On Assets, with a value of -261.16%, AMIX is doing worse than 95.16% of the companies in the same industry.
The Return On Equity of AMIX (-463.24%) is worse than 86.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -261.16% | ||
| ROE | -463.24% | ||
| ROIC | N/A |
ROA(3y)-339.93%
ROA(5y)N/A
ROE(3y)-388.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AMIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
AMIX has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, AMIX has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -15.69, we must say that AMIX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMIX (-15.69) is worse than 84.95% of its industry peers.
A Debt/Equity ratio of 0.36 indicates that AMIX is not too dependend on debt financing.
AMIX has a Debt to Equity ratio (0.36) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -15.69 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
AMIX has a Current Ratio of 4.26. This indicates that AMIX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMIX (4.26) is better than 71.51% of its industry peers.
AMIX has a Quick Ratio of 4.26. This indicates that AMIX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AMIX (4.26) is better than 76.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.26 | ||
| Quick Ratio | 4.26 |
3. Growth
3.1 Past
The earnings per share for AMIX have decreased strongly by -18089.44% in the last year.
EPS 1Y (TTM)-18089.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-654.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
AMIX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.55% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y53.89%
EPS Next 2Y15.2%
EPS Next 3Y13.55%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
AMIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AMIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AMIX's earnings are expected to grow with 13.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.2%
EPS Next 3Y13.55%
5. Dividend
5.1 Amount
No dividends for AMIX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AUTONOMIX MEDICAL INC
NASDAQ:AMIX (1/2/2025, 7:57:32 PM)
After market: 3.3511 -0.02 (-0.56%)3.37
-0.39 (-10.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.4%
Inst Owner Change239.44%
Ins Owners31.17%
Ins Owner Change0%
Market Cap5.96M
Analysts85.71
Price Target28.56 (747.48%)
Short Float %8.48%
Short Ratio0.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.97 | ||
| P/tB | 1.97 | ||
| EV/EBITDA | N/A |
EPS(TTM)-14.01
EYN/A
EPS(NY)-11.02
Fwd EYN/A
FCF(TTM)-4.7
FCFYN/A
OCF(TTM)-4.68
OCFYN/A
SpS0
BVpS1.71
TBVpS1.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -261.16% | ||
| ROE | -463.24% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-339.93%
ROA(5y)N/A
ROE(3y)-388.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.26 | ||
| Quick Ratio | 4.26 | ||
| Altman-Z | -15.69 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18089.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-654.71%
EPS Next Y53.89%
EPS Next 2Y15.2%
EPS Next 3Y13.55%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-504.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-258.5%
OCF growth 3YN/A
OCF growth 5YN/A